<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>56c49999-29d8-41a8-adfb-af86a78a4fe1</id>
  <name>N_methyl_D_aspartate_MDA_Receptor Antagonist Order Group</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~56c49999-29d8-41a8-adfb-af86a78a4fe1~NAME~N_methyl_D_aspartate_MDA_Receptor Antagonist Order Group}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;Technical Note:&lt;/p&gt;&lt;p&gt;Please use the following links&lt;/p&gt;&lt;p&gt;·&amp;nbsp;&amp;nbsp; &lt;u&gt;&lt;strong&gt;Clinical Knowledge Topic for low dose ketamine&lt;/strong&gt;&lt;/u&gt;&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;u&gt;&lt;strong&gt;Dynamed plus&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;&lt;p&gt;https://www.dynamed.com/drug-monograph/ketamine&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;u&gt;&lt;strong&gt;Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management&amp;nbsp;&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;&lt;p&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023582/&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;For use in the emergency department, intensive care unit, or other services, as an additional pain management option the recommended ketamine dose is 0.1 – 0.3 mg/kg generally combined with an opioid with a lower than normal dose.&lt;br&gt;&amp;nbsp;&lt;br&gt;A July 2018 US Anaesthesia and Pain Consensus Guideline recommends that ketamine bolus doses do not exceed 0.35 mg/kg, and infusions for acute pain generally do not exceed 1 mg/kg per hour in settings without intensive monitoring. They suggest that for opioid naïve patients lower doses (ie, 0.1 - 0.5 mg/kg per hour) should achieve the best balance of analgesia and adverse effects in acute pain, while opioid-tolerant patients may require higher doses (ie, 0.1 - 0.5 mg/kg per hour).&lt;br&gt;&amp;nbsp;&lt;br&gt;Relative contraindications include: poorly controlled cardiovascular disease, psychosis, pregnancy, cirrhosis, and elevated intraocular pressure. Intranasal (IN) ketamine at a dose of 1 mg/kg appears to provide effective analgesia comparable to 0.1 mg/kg IV or IM and of quicker onset than IM; and also providing the same pain relief as 0.15 mg/kg morphine in trauma patients.&lt;br&gt;·&amp;nbsp;&amp;nbsp; &lt;u&gt;&lt;strong&gt;Clinical Knowledge Topic for low dose ketamine&lt;/strong&gt;&lt;/u&gt;&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;u&gt;&lt;strong&gt;Dynamed plus&lt;/strong&gt;&lt;/u&gt;&lt;br&gt;·&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;u&gt;&lt;strong&gt;Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management&amp;nbsp;&lt;/strong&gt;&lt;/u&gt;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="N-methyl-D-aspartate (MDA) Receptor Antagonist">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2ae5689d-4345-4ce5-9f6b-90338b89a89b" concept_name="PHARM ketamine injection Order" max="1" path="/items" name="ketamine injection; 0.1 mg/kg/dose, intravenous, once, Administer IV push over 5 minutes, slow infusion over 15 minutes"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="54db1db0-f72f-4caa-97ed-f3b27b18d418" concept_name="PHARM ketamine infusion Order" max="1" path="/items" name="ketamine IV infusion (adult); 0.1 mg/kg/hr, intravenous, continuous"/>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
</template>